<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01115634</url>
  </required_header>
  <id_info>
    <org_study_id>Royan-skin-002</org_study_id>
    <nct_id>NCT01115634</nct_id>
  </id_info>
  <brief_title>Autologous Fibroblast Transplantation in Facial Deformities</brief_title>
  <official_title>Autologous Transplantation of Cultured Fibroblast for Facial Contour Deformities</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Royan Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Royan Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Beautiful skin requires maintenance of proper care. Skin exercise, protections from direct&#xD;
      sunlight or harsh wind, and maintaining a healthy diet are some of the ways of having a good&#xD;
      and radiant skin. However despite all the care taken passage of time will bring about&#xD;
      conditions that will automatically lead to skin aging, which may require certain therapeutic,&#xD;
      care. Fibroblasts are cells that synthesize the extracellular matrix and collagen and play a&#xD;
      critical role in wound healing and maintenance of healthy skin. Loosing of fibroblast cell is&#xD;
      the main problem in aging and wrinkles and non-healed skin wounds. Therefore proliferation of&#xD;
      skin fibroblast along with differentiation of stem cells in the skin tissue is the best&#xD;
      method for healing.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Autologous cultured fibroblast is derived from in vitro expansion of fibroblasts harvested&#xD;
      from the patient's normal skin. Biopsies from behind a patient's ear are the source of&#xD;
      fibroblasts, which are isolated, expanded through cell culture, and used for the correction&#xD;
      of facial contour deformities such as nasolabial folds, glabellar crease, deep wrinkles of&#xD;
      the forehead, and acne scars. Prior to final packaging, cell viability is assessed to be at&#xD;
      least 85%.&#xD;
&#xD;
      Each single use container of autologous cultured fibroblasts has approximately 20 million&#xD;
      cells aseptically processed and suspended in 1 mL of sterile, buffered Dulbecco's Modified&#xD;
      Eagles Medium (DMEM). Both the biopsy transport media and the cell culture media contain&#xD;
      gentamicin. Residual quantities of gentamicin up to 5 Âµg/mL may be present in the Cell&#xD;
      product&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">November 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>2-point shift in at least one treated area using a standardized 7-point photoguide</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Nasolabial Folds</condition>
  <condition>Glabellar Crease</condition>
  <condition>Deep Wrinkles of the Forehead</condition>
  <condition>Acne Scars</condition>
  <arm_group>
    <arm_group_label>Fibroblast</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Injection of autologous cultured fibroblast</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Fibroblast</intervention_name>
    <description>20 million cell in three injection</description>
    <arm_group_label>Fibroblast</arm_group_label>
    <other_name>cell alone</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>fibroblast and gel</intervention_name>
    <description>20 million cell in three injection plus filler</description>
    <arm_group_label>Fibroblast</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Available and willing to attend all follow-up visits.&#xD;
&#xD;
          -  Age &gt; 18 years.&#xD;
&#xD;
          -  Able and willing to give informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known allergy or sensitivity to collagen fillers&#xD;
&#xD;
          -  The subject has received a soft tissue augmentation to the area to be treated within&#xD;
             the last 6 months.&#xD;
&#xD;
          -  Subject is unwilling to forgo any cosmetic augmentation procedures for the duration of&#xD;
             the study.&#xD;
&#xD;
          -  The subject has received autologous fat transfer in the last 6 months.&#xD;
&#xD;
          -  Subject is suffering from facial Kaposi's sarcoma.&#xD;
&#xD;
          -  The subject has active skin diseases or inflammation on or near the area of injection&#xD;
&#xD;
          -  positive HIV, HBV, HCV&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Saeed Shafiyan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Royan Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nasser Aghdami, MD., PhD</last_name>
    <role>Study Director</role>
    <affiliation>Royan Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Royan Institute</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <link>
    <url>http://www.royaninstitute.org</url>
    <description>Related Info</description>
  </link>
  <verification_date>May 2010</verification_date>
  <study_first_submitted>May 1, 2010</study_first_submitted>
  <study_first_submitted_qc>May 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2010</study_first_posted>
  <last_update_submitted>July 20, 2016</last_update_submitted>
  <last_update_submitted_qc>July 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 21, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fibroblast</keyword>
  <keyword>Cell transplantation</keyword>
  <keyword>Facial deformities</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Congenital Abnormalities</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

